Amyotrophic Lateral Sclerosis · 2011 · 34 citations · 17 references
MedicineNeurologyNeuroscienceClinical NeuroscienceNeuropathologySurvival AnalysisAmyotrophic Lateral SclerosisMotor Neuron DiseasesMotor Neuron DisordersAmyotrophic Lateral Sclerosis PathologyClinical HeterogeneityNeurodegenerative Disease EpidemiologyOverall MortalitySurvival RatesUpper Motor Neuron DysfunctionUpper Motor Neuron Involvement
The demography, survival, and motor phenotypes of amyotrophic lateral sclerosis (ALS) patients have been rarely described in Hispanic countries. The clinical characteristics and survival of a series of Mexican ALS patients are described. Mexican patients with definite ALS were included in a five-year retrospective longitudinal study. Their demographic and clinical features, cumulative survival rates, and independent predictive factors for survival were analysed. Sixty-one definite ALS patients were included. The median follow-up period was 35 months (range 12-108 months). Males were predominant (1.8: 1), the mean age at onset was 47.5 ± 10.5 years, and the median interval from onset to diagnosis was 12 months. Spinal onset occurred in 66% of patients. Upper motor neuron phenotype was predominant in 53% of patients. The overall mean survival from onset was 68.6 months, and from diagnosis was 57.8 months. Longer survival was determined in patients aged ≤ 40 years (54.7 months) compared with other age groups (p = 0.006). In conclusion, the clinical heterogeneity, male predominance, and survival rates in our sample are consistent with those of other studies. Patients in this series had a younger age at onset and a clear trend toward longer survival compared with those of other population studies.
17
Prognosis in amyotrophic lateral sclerosis
Michael A. del Aguila, W.T. Longstreth, Valerie McGuire et al. · Neurology · 2003 · 450 citations
The natural history of amyotrophic lateral sclerosis
S. P. Ringel, J. R. Murphy, Margit Alderson et al. · Neurology · 1993 · 244 citations